戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and 5-HT4 receptor antagonists, but not by a 5-HT3 receptor antagonist.
2  was less affected by VMN infusions with the 5-HT3 receptor antagonist.
3 nged efficacy, and acts synergistically with 5-HT3 receptor antagonists.
4                Similar pretreatment with the 5-HT3 receptor antagonist 3-tropanyl-3,5-dichlorobenzoat
5                   Rats were infused with the 5-HT3 receptor antagonist, 3-tropanyl-indole-3 carbonyla
6                                Aprepitant, a 5-HT3 receptor antagonist (5HT3-RA), and dexamethasone a
7 kg-1, i.v.), or treatment with the selective 5-HT3 receptor antagonist alosetron (30 microg kg-1, i.v
8                    Although tropisetron is a 5-HT3 receptor antagonist and an alpha7nAChR partial ago
9 1) receptor antagonist in conjunction with a 5-HT3 receptor antagonist and corticosteroid in patients
10             Rolapitant in combination with a 5-HT3 receptor antagonist and dexamethasone is well tole
11             Rolapitant in combination with a 5-HT3 receptor antagonist and dexamethasone is well-tole
12 isetron; 500 ng), or were coinfused with the 5-HT3 receptor antagonist and the 5-HT2A/2C receptor ago
13 rolapitant, in combination with a serotonin (5-HT3) receptor antagonist and dexamethasone, for the pr
14 d Fos-LI in the DVC of ondansetron (1 mg/kg; 5-HT3 receptor antagonist) and vehicle-treated rats foll
15               A combination of aprepitant, a 5-HT3 receptor antagonist, and dexamethasone is recommen
16 combination of an NK1 receptor antagonist, a 5-HT3 receptor antagonist, and dexamethasone.
17 f ondansetron, a selective serotonin type-3 (5-HT3) receptor antagonist, attenuates cholecystokinin (
18 by DPPIV inhibition or by cholecystokinin or 5-HT3 receptor antagonists, but was inhibited by atropin
19                     ICS205-930 (1 microM), a 5-HT3 receptor antagonist, completely blocked the 5-HT-i
20 ) and palonosetron (a 5-hydroxytryptamine-3 [5-HT3] receptor antagonist) for the prevention of acute
21 o 3.8 +/- 1.1 spikes s(-1)) by the selective 5-HT3 receptor antagonist granisetron.
22 -HT response was completely abolished by the 5-HT3 receptor antagonist, granisetron (0.5 mg kg-1).
23  wide dynamic range neurons are inhibited by 5-HT3 receptor antagonists in rats following spinal nerv
24  coefficient = 1.8) that were blocked by the 5-HT3 receptor antagonist ondansetron (IC50 = 103 pM) an
25                                          The 5-HT3 receptor antagonist ondansetron is a good candidat
26 led to do so in Tph1(-/-) colon; and (9) the 5-HT3 receptor antagonist ondansetron, which reduced CMM
27 ivity effect of intrathecal injection of the 5-HT3 receptor antagonist ondansetron.
28 rotonin and this effect was blocked with the 5-HT3-receptor antagonist ondansetron.
29 njection of tropisetron (200 microg kg-1), a 5-HT3 receptor antagonist, significantly attenuated the
30 whisking frequencies, and selective 5-HT2 or 5-HT3 receptor antagonists suppress this rhythmic firing
31    Unilateral infusion of selective 5-HT2 or 5-HT3 receptor antagonists suppresses ipsilateral whiski
32 otetralin (DPAT; 0.1 mg/kg and 0.3 mg/kg) or 5-HT3 receptor antagonist tropisetron (0.3 mg/kg) treatm
33 fusions with 100 ng, 250 ng or 500 ng of the 5-HT3 receptor antagonist, tropisetron.
34                                          The 5-HT3 receptor "antagonists' (+)-tubocurarine and quipaz
35 urthermore, this mutation also converted the 5-HT3 receptor antagonist/very weak partial agonist, apo